Eighteen patients with hyperosmolar non-ketotic diabetic coma were studied retrospectively to identify factors affecting prognosis and to review treatment. This condition affected older women two-thirds of whom were unrecognised diabetics. Eight (44%) died. Mortality correlated with age above 60, uraemia and hyperosmolarity, but not with the degree or rate of fall of hyperglycaemia. Hyperglycaemia responded to rehydration and insulin, but in all patients serum osmolarity remained high for several days. In 14 patients (78%) the serum sodium concentration initially increased and in four (22%) serum osmolarity increased. This persistence or worsening of the hyperosmolar state can be avoided without the risk of cerebal oedema by replacing the fluid and electrolyte deficits over 48 hours and using 5% dextrose for the water deficit.
Although hyperosmolar non-ketotic diabetic coma is an uncommon metabolic emergency of the common disease diabetes mellitus, it is a highly lethal one. Optimal treatment is not clearly defined in these elderly patients who have little tolerance for disturbances of body tonicity or extracellular volume. The risk of continuing hyperosmolarity must be balanced against the risks of rapid osmolar changes and cerebal oedema and of pulmonary oedema. We have reviewed the response of 18 patients and have developed a rational approach to fluid and electrolyte management.
PATIENTS AND RESULTS

Presentation and Treatment
The case records were reviewed of the 18 patients who presented to the Royal Adelaide Hospital between August 1969 to August 1976 and satisfied the criteria in Table 1 .
There were 13 females and five males of median age 64 (range 41-77). two-thirds (12118) were not known diabetics. All had an abnormal sensorium and two had had focal fits. Ten (56070) had obvious precipitating factors: infection in nine and cessation of hypoglycaemic medication in one. All patients were clinically dehydrated and 13 (72%) admitted to polyuria and polydipsia for the preceding two to four days. Equal numbers of patients were treated in the Endocrine and Metabolic Ward or Intensive Care Unit as in the general medical wards. From 1969 to 1974 (14 patients) treatment was with high dose intermittent insulin (70-320 units over 40 hours) with 0.9% sodium chloride as the fluid replacement solution. From 1974 to 1976 (4 patients) low dose continuous intravenous or hourly intramuscular insulin (18-126 units over 40 hours) and alternating 0.9% and 0.45% sodium chloride were given.
Clinical Progress
Thirteen (72%) returned to a normal conscious state by 72 hours but three of the patients from 1969 to 1974 and two of those from 1974 to 1976 died without a change in conscious state (four by 72 hours and one 144 hours after admission). Three other patients died -a total mortality of 8/18 (44070). One had ischaemic heart disease and died of an arrhythmia several days after the metabolic disturbance had settled; one died of a clinically diagnosed pulmonary embolus after 10 days; and one died with pneumonia after 11 days. All patients who died were over 60, had a serum osmolarity > 350 mosm/l and a serum urea concentration> 20 mmolll.
Biochemical Progress
Hyperglycaemia was easily controlled in all patients and the plasma glucose concentration was < 12 mmolll by 24 hours in nine of the patients from 1969 to 1974 and one of those from 1974 to 1976. There were no differences in the degree or rate of resolution of hyperglycaemia between patients who died or survived.
There were three patterns of changes in serum osmolarity and sodium concentration. In three patients (Group A) values slowly decreased to normal over 72 to 140 hours. In 11 (Group B) the serum sodium concentration initially increased and partly balanced the decrease of serum glucose concentration, so that the serum osmolarity decreased over 72 to 160 hours. In four patients (Group C) the increase in serum sodium concentration more than compensated for the decrease in serum glucose concentration and serum osmolarity increased and remained above admission values for more than six hours. Thereafter values decreased to normal over 96 to 184 hours. Three of the four patients in whom hyperosmolarity worsened had received 0.9070 and the other alternating 0.45070 and 0.9070 sodium chloride.
Patients in Group A were more hyperosmolar on admission ( Table 2 ) and all died, two without a change in consciousness. On admission the biochemistry of Groups B and C was similar. In these groups the three who died without a change of consciousness were hypernatraemic at the time of death. 
DISCUSSION
This study confirms that hyperosmolar nonketotic coma has a high mortality (441110) and tends to occur in elderly, female, undiagnosed diabetics. 1 ,2 Mortality was related to age above 60, uraemia and hyperosmolarity, but not to the degree or rate of fall of hyperglycaemia. Although hyperglycaemia responded to high or low dose insulin, hyperosmolarity took several days to abate and worsened for more than six hours in four patients.
Hyperosmolarity is recognised as a cause of coma, early death and permanent brain damage. 3 -6 In our series the five patients who died without a change in conscious state were still hyperosmolar and among the survivors the improvement in sensorium and hyperosmolarity were parallel. The observed .,low correction or worsening of the hyperosmolar state suggests that our therapy was inadequate. On the other hand, correction of hyperosmolarity has its risks. First, cerebral oedema may occur because brain cells increase their osmolar content during the period of hyperosmolarity and this may result in brain swelling if therapy decreases extracellular osmolarity rapidly. 7 Second, pulmonary oedema may occur in these elderly patients.
Therapy requires consideration of the water deficit reflected by hyperosmolarity, of the sodium deficit reflected by extracellular volume depletion and of continuing losses and requirements. The water deficit varies from 4.5 to 18 litres 8 and can be estimated by predicting the serum sodium concentration that will occur when hyperglycaemia is corrected and water moves from the extracellular to the intracellular compartment.' Total body sodium depletion undoubtedly exists, but is less than with ketoacidosis because ketonuria is absent and urinary cation loss is correspondingly less. The actual sodium deficit varies but is approximately 400 mmol. 8 Continuing losses are often ignored or replaced inappropriately. We have found that urine produced during treatment has sodium and potassium concentrations between 50 to 70 and 15 to 30 mmolll respectively. Others 8 have found even lower urinary sodium concentrations (3-22 mmolll) . In summary, the deficits are 4.5 to 18 litres of water and 400 mmol of sodium; the continuing urinary losses are approximately 0.35070 sodium chloride and the basic requirements are 1 to 2 litres of water and 60 mmol of sodium per day.
The observed slow correction of hyperosmolarity is easily understood; 0.9070 (154 mmolll) or even alternating 0.45070 (77 mmolll) and 0.9070 sodium chloride have too much sodium. More water and less sodium should have been given. The optimal rate of administration is probably one which corrects the hyperosmolar state over approximately 48 hours since this avoids the risks of cerebral oedema by allowing brain cells to reduce their osmolar content. 9.10 This reduction of cerebral osmolar content is probably quicker if the plasma glucose concentration is maintained above normal levels ( > 12 mmolll). 11 In addition to replacing urine losses (e.g. with 0.45070 sodium chloride plus 26 mmol of potassium as the chloride or phosphate per litre), the water deficit and on-going requirements could be given over 48 hours (e.g. as 5070 dextrose plus 13 mmol of potassium as the chloride or phosphate per litre). Most of the sodium deficit should be replaced in the first 12 hours to counter the rapid decrease of serum glucose (e.g. as 2 litres of 0.9070 sodium chloride). If hypovolaemia is present, plasma expanders with central venous pressure monitoring are indicated.
Although it seems paradoxical to be giving glucose solutions to hyperglycaemic patients the solution is isotonic and the patients are carbohydrate-depleted and invariably respond to insulin.
The recommended regime is simple and allows a separate assessment of the three interacting components of fluid and electrolyte management of hyperosmolar non-ketotic coma:
the immediate problem of hypovolaemia, the replacement over 48 hours of the water and sodium deficits, and the ongoing replacement of urinary losses and basal req uiremen ts.
